Assessment of Preemptive Analgesic Effect of Caldolor(R) vs. Ofirmev(R) on Third Molar Surgery: A Prospective, Randomized, single-blinded Clinical Trial
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 29 Oct 2018
Price : $35 *
At a glance
- Drugs Ibuprofen (Primary) ; Paracetamol
- Indications Postoperative pain
- Focus Therapeutic Use
- 29 Oct 2018 Results presented in the Cumberland Pharmaceuticals media release.
- 29 Oct 2018 According to a Cumberland Pharmaceuticals media release, data from this trial was published online in the Journal of Oral and Maxillofacial Surgery, October 15, 2018.
- 19 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jan 2017.